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ABSTRACT
Objectives To evaluate haemoglobin A1c (HbA1c)i n
diagnosing diabetes and identify the optimal HbA1c
threshold to be used in Chinese adults.
Design Multistage stratified cross sectional
epidemiological survey.
Setting Shanghai, China, 2007-8.
Participants 4886 Chinese adults over 20 years of age
with no history of diabetes.
Main outcome measures Performance of HbA1c at
increasing thresholds for diagnosing diabetes.
Results The area under the receiver operating
characteristics curve for detecting undiagnosed diabetes
was 0.856 (95% confidence interval 0.828 to 0.883) for
HbA1c alone and 0.920 (0.900 to 0.941) for fasting
plasma glucose alone. Very high specificity (96.1%, 95%
confidence interval 95.5% to 96.7%) was achieved at an
HbA1c threshold of 6.3% (2 SD above the normal mean).
Moreover, the corresponding sensitivity was 62.8%
(57.1% to 68.3%), which was equivalent to that of a
fasting plasma glucose threshold of 7.0 mmol/l (57.5%,
51.7% to 63.1%) in detecting undiagnosed diabetes. In
participants at high risk of diabetes, the HbA1c threshold
of 6.3% showed significantly higher sensitivity (66.9%,
61.0% to 72.5%) than both fasting plasma glucose
≥7.0 mmol/l (54.4%, 48.3% to 60.4%) and HbA1c ≥6.5%
(53.7%, 47.6% to 59.7%) (P<0.01).
Conclusions An HbA1c threshold of 6.3% was highly
specific for detecting undiagnosed diabetes in Chinese
adultsandhadsensitivitysimilartothatofusingafasting
plasma glucose threshold of 7.0 mmol/l. This optimal
HbA1c threshold may be suitable as a diagnostic criterion
for diabetes in Chinese adults when fasting plasma
glucoseandoralglucosetolerancetestsarenotavailable.
INTRODUCTION
Diabetes is often not diagnosed until complications
appear,andapproximately30%ofpeoplewithdiabetes
may be undiagnosed.
12Additionally, complications of
diabeteshavebecome a leadingcause ofimpairment of
human health.
3 More efficient approaches to diagnos-
ing diabetes urgently need be developed to improve
health care for patients with diabetes.
Existing diagnosticmethodsincludeplasma glucose
specific tests (fasting plasma glucose or oral glucose
tolerance test) and glycated haemoglobin A1c
(HbA1c),althoughthelastmethodhasnotbeenrecom-
mendedasadiagnostictoolmainlyowingtothelackof
standardised results.
45 The special requirements for
the oral glucose tolerance test, or to obtain fasting
and two hour postprandial plasma glucose, limit the
clinical application of these methods. HbA1c tests are
convenient and easy to do without regard to the time
elapsed since the previous meal.
SeveralmethodshavebeenusedtomeasureHbA1c,
including low performance liquid chromatography,
ion exchange high performance liquid chromatogra-
phy, capillary electrophoresis, and immunoassay.
Under the leadership of the National Glycohemoglo-
bin Standardization Program, great progress has been
made in standardising HbA1c assays in many nations
worldwide,
67and high performance liquid chromato-
graphy is highly recommended. In China, hospitals in
large and medium sized cities that participated in the
Chinese Ministry of Health Quality Assessment Pro-
gram for HbA1c used this method. In recent years,
HbA1chasbeenwidelyusedasameasureofglycaemic
control in patients with diabetes after treatment, and
efforts to further standardise its use have continued.
89
Substantial evidence shows that HbA1c may be a
useful tool for screening for and diagnosis of
diabetes.
10-14 An HbA1c threshold of 6.5% was pro-
posed for the diagnosis of diabetes on the basis of the
datafromtheNationalHealthandNutritionExamina-
tion Survey.
1011 However, findings from previous stu-
dies evaluating HbA1c as a screening tool have
suggested that the optimal threshold for detecting dia-
betes may vary by ethnic group.
111215 Recently, an
international expert committee with members
appointed by the American Diabetes Association, the
European Association for the Study of Diabetes, and
the International Diabetes Federation published a
report on the role of the HbA1c assay in the diagnosis
of diabetes. It noted that an HbA1c value of 6.5% is
sufficiently sensitive and specific to identify people
who are at risk of developing retinopathy and who
should therefore be diagnosed as having diabetes.
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epidemiologicalstudiesthatincludedanEgyptianpopu-
lation, Pima Indians, and the US National Health and
Nutrition Examination Survey population.
16 However,
the performance of HbA1c in detecting diabetes in the
Chinese population remains unknown. The purpose of
thisstudywastoevaluatetheefficiencyofHbA1cindiag-
nosing diabetes and to identify the optimal threshold in
theadultChinesepopulationbyusinghighperformance
liquid chromatography.
METHODS
Study design and population
Thiscrosssectionalepidemiologicalsurveyofdiabetes
and metabolic syndrome (Shanghai Diabetes Study II,
SHDS II) in six communities in Shanghai between
May 2007andAugust2008followed amultistagestra-
tified design. We divided each community into five
groups according to age (20-29, 30-39, 40-49, 50-59,
≥60 years). The sampling proportion within each
group was based on the age structure of the commu-
nity. The average response rate was 95.9%. Exclusion
criteria were cancer, severe psychiatric disturbance,
chronickidneydisease,pregnancy,andglucocorticoid
treatment. A total of 5372 Chinese people aged 14 to
79 years participated in the survey. All participants
were expected to complete a uniform questionnaire
containing questions about the histories of current
and previous illness and medical treatment. Standard
75 g oral glucose tolerance tests were done in partici-
pants without known diabetes. We excluded 486 peo-
ple, comprising 360 previously diagnosed as having
diabetes, 87 with missing questionnaire data, and 39
agedunder20years.Weanalyseddatafrom4886par-
ticipants aged over 20. Each participant gave written
informed consent
Anthropometric and biochemical measurements
Participantsarrivedatthecommunityservicecentreat6
amaftera10hourovernightfast.Eachparticipanthada
physicalexaminationincludingmeasurementofheight,
weight, waist circumference, and blood pressure. We
calculated body mass index as weight (kg) divided by
squared height (m). We measured waist circumference
at the horizontal plane between the inferior costal mar-
gin and the iliac crest on the mid-axillary line. Blood
pressure was the average of three measurements made
with a sphygmomanometer at two minute intervals.
Afterafastingvenousbloodsamplewasdrawnfrom
the antecubital vein, each participant had a 75 g oral
glucose tolerance test. We measured plasma glucose
concentrations by the glucose oxidase method. We
measured serum lipid profiles, including triglycerides,
total cholesterol, high density lipoprotein cholesterol,
and low density lipoprotein cholesterol, by standard
commercial methods on a parallel, multichannel ana-
lyser (Hitachi 7600-020, Tokyo, Japan). An experi-
enced technician, who was blinded to the study,
measured HbA1c by high performance liquid chroma-
tography (HLC-73G7, Tosoh, Japan). We measured
HbA1c, fasting plasma glucose, and two hour post-
load plasma glucose within two hours of collection of
blood. The Shanghai Diabetes Institute successfully
participated in the HbA1c Quality Assessment Pro-
gram of the Chinese Ministry of Health between
2006 and 2008. The HbA1c inter-assay and intra-
assaycoefficientsofvariationwere<0.4%,and<0.6%.
Definitions
The oral glucose tolerance test is considered to be the
gold standard for diagnosing diabetes.
1718 The glycae-
mic thresholds for diagnosis of diabetes and impaired
glucose regulation were based on the 1999 World
Health Organization (WHO) criteria. Diabetes is
defined as fasting plasma glucose of at least
7.0 mmol/l, two hour post-load plasma glucose of at
least 11.1 mmol/l, or both.
4 Impaired glucose regula-
tion is defined as impaired fasting glucose (fasting
plasma glucose ≥6.1 mmol/l and <7.0 mmol/l and
two hour post-load plasma glucose <7.8 mmol/l),
impaired glucose tolerance (fasting plasma glucose
<6.1 mmol/l and two hour post-load plasma glucose
≥7.8 mmol/l and <11.1 mmol/l), and impaired fasting
glucose with impaired glucose tolerance (fasting
plasma glucose ≥6.1 mmol/l and <7.0 mmol/l and
two hour post-load plasma glucose ≥7.8 mmol/l and
<11.1mmol/l).Hyperglycaemiccategoriesofdiabetes
areisolatedhighfastingplasmaglucoseconcentrations
(fasting plasma glucose ≥7.0 mmol/l and two hour
post-load plasma glucose <11.1 mmol/l), isolated
high two hour post-load plasma glucose concentra-
tions (fasting plasma glucose <7.0 mmol/l and two
hour post-load plasma glucose ≥11.1 mmol/l), and
high fasting plasma glucose concentrations with high
two hour post-load plasma glucose concentrations
(fasting plasma glucose ≥7.0 mmol/l and two hour
post-load plasma glucose ≥11.1 mmol/l).
Statistical analysis
We used SPSS version 11.5 for all statistical analyses.
We presented continuous variables as means (SD),
Sample (n=5653)
Age 14-79 years (n=5372)
Aged over 20 years (n=4886)
Excluded (n=281):
  Malignancy (n=146)
  Hyperparathyroidism (n=83)
  Hepatitis B (n=25)
  Anaemia (n=8)
  Glucocorticoid treatment (n=7)
  Chronic kidney disease (n=6)
  Hypothyroidism (n=3)
  Pancreatitis (n=2)
  Schizophrenia (n=1)
Excluded (n=486):
  Previous diagnosis of diabetes (n=360)
  Missing questionnaire (n=87)
  Aged 14-19 years (n=39)
Fig 1 | Flow diagram of recruitment of participants
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medians (interquartile range). We expressed categori-
cal variables as percentages. We used Pearson correla-
tion analysis to investigate the association of HbA1c
with blood glucose concentrations (that is, fasting
plasma glucose and two hour post-load plasma glu-
cose). We used the method described by Hanley and
McNeiltocomparetheareaunderthereceiveroperat-
ing characteristics curve for HbA1c and fasting plasma
glucose predicting undiagnosed diabetes.
19 We exam-
ined the sensitivity and specificity of HbA1c with the
receiveroperatingcharacteristicscurvetoidentifypar-
ticipants as having undiagnosed diabetes. Thresholds
were 1, 2, 3, and 4 standard deviations above the nor-
malmean. Weconsidered Pvalues lessthan0.05 to be
statistically significant for a two sided test.
RESULTS
Thefinaldatasetincluded4886participants(1828men
and 3058 women) aged over 20 (median 49.4, inter-
quartile range 37.9-57.7 years) from May 2007 to
August 2008 (fig 1). Table 1 shows the clinical charac-
teristics of the participants. We found no significant
differences in age, low density lipoprotein cholesterol,
fastingplasmaglucose,andtwo hourpost-loadplasma
glucose between men and women. Women had lower
valuesofbodymassindex,waistcircumference,blood
pressure,triglycerides,andHbA1candhigherlevelsof
total cholesterol and high density lipoprotein choles-
terol than did men (all P<0.01). The percentage of
undiagnosed diabetes in women was significantly
lower than that in men (P<0.01).
The dataset included data from 3748 people with
normal glucose tolerance, 837 with impaired glucose
regulation, and 301 with diabetes. Of the 837 partici-
pants with impaired glucose regulation, 199 (23.8%)
had impaired fasting glucose, 534 (63.8%) had
impaired glucose tolerance, and 104 (12.4%) had
impaired fasting glucose with impaired glucose toler-
ance. Of the 301 participants with diabetes, 71 (24%)
had isolated high fasting plasma glucose concentra-
tions, 128 (43%) had isolated high two hour post-load
plasma glucose concentrations, and 102 (34%) had
high fasting plasma glucose concentrations with high
two hour post-load plasma glucose concentrations.
HbA1c and either fasting plasma glucose or two hour
post-loadplasmaglucoseweresignificantlycorrelated,
with correlation coefficients of 0.619 (P<0.001) and
0.622 (P<0.001) on the basis of Pearson correlation
analysis.
The receiver operating characteristics curve shown
infigure2representsthediagnosticaccuracyofHbA1c
for undiagnosed diabetes. The area under the curve
was 0.856 (95% confidence interval 0.828 to 0.883)
for HbA1c alone and 0.920 (0.900 to 0.941) for fasting
plasma glucose alone. The two areas differed signifi-
cantly from each other (P<0.001). Table 2 shows the
sensitivity, specificity, positive predictive value, nega-
tive predictive value, positive likelihood ratio, and
negative likelihood ratio for identifying diabetes at
HbA1c thresholds of 1, 2, 3, and 4 standard deviations
(0.4%) above the mean of normal glucose tolerance
(5.5%). When the number of standard deviations
increased, sensitivity decreased and specificity
increased. An HbA1c threshold of 1 SD above the nor-
mal mean (5.9%) showed a very high sensitivity of
77.7% (95% confidence interval 72.6% to 82.3%) and
a moderate specificity of 78.2% (77.0% to 79.4%) for
detecting undiagnosed diabetes. These findings coin-
cided with the threshold selected by the closest dis-
tance to the left upper corner of the receiver
operating characteristics curve, which indicated the
best trade-off between sensitivity and specificity. A
high specificity of 96.1% (95.5% to 96.7%) was
Table 1 |Clinical characteristics of participants. Values are median (interquartile range) unless stated otherwise
Characteristics Total (n=4886) Men (n=1828) Women (n=3058)
Age (years) 49.4 (37.9-57.7) 49.0 (37.4-59.0) 49.5 (38.2-56.9)
Body mass index (kg/m
2) 23.5 (21.4-25.9) Mean 24.1 (SD 3.3) 23.2 (21.2-25.5)*
Waist circumference (cm) 79.0 (72.0-86.0) 84.0 (77.0-90.0) 76.0 (70.0-83.0)*
Systolic blood pressure (mm Hg) 120.0 (110.0-130.0) 120.0 (112.1-134.0) 120.0 (109.0-130.0)*
Diastolic blood pressure (mm Hg) 78.0 (70.0-82.0) 80.0 (71.7-88.0) 76.0 (70.0-80.0)*
Total cholesterol (mmol/l) 4.5 (4.0-5.2) 4.5 (3.9-5.1) 4.6 (4.0-5.3)*
Triglycerides (mmol/l) 1.3 (0.9-1.9) 1.5 (1.0-2.2) 1.2 (0.8-1.7)*
High density lipoprotein cholesterol (mmol/l) 1.3 (1.1-1.5) 1.2 (1.0-1.4) 1.4 (1.2-1.6)*
Low density lipoprotein cholesterol (mmol/l) 2.9 (2.4-3.4) 2.9 (2.4-3.4) 2.9 (2.4-3.4)
Fasting plasma glucose (mmol/l) 5.2 (4.8-5.6) 5.2 (4.7-5.6) 5.2 (4.8-5.6)
2 hour post-load plasma glucose (mmol/l) 6.0 (5.0-7.2) 5.9 (4.8-7.3) 6.0 (5.1-7.2)
HbA1c (%) 5.6 (5.3-5.9) 5.6 (5.4-5.9) 5.6 (5.3-5.8)*
Normal glucose tolerance—No (%) 3748 (76.7) 1362 (74.5) 2386 (78.0)*
Impaired glucose regulation—No (%) 837 (17.1) 315 (17.2) 522 (17.1)
Undiagnosed diabetes—No (%) 301 (6.2) 151 (8.3) 150 (4.9)*
Fasting plasma glucose ≥7.0 mmol/l—No (%) 173 (58) 87 (58) 86 (58)
2 hour post-load plasma glucose ≥11.1 mmol/l and
fasting plasma glucose <7.0 mmol/l—No (%)
128 (43) 64 (42) 64 (43)
*P<0.01 compared with men.
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the normal mean), together with a low negative like-
lihoodratioof0.4(0.3to0.5),ahighpositivelikelihood
ratio of 16.2 (13.7 to 19.1), and a negative predictive
value of 97.5% (97.0% to 98.0%).
Subsequently,wecomparedthesensitivityofHbA1c
thresholds of 6.3% and 6.5% (as recommended by the
international expert committee) with a fasting plasma
glucosethresholdof7.0mmol/l.Thesensitivitiesofan
HbA1c threshold of 6.3% and this fasting plasma glu-
cose concentration in detecting undiagnosed diabetes
were 62.8% (57.1% to 68.3%) and 57.5% (51.7% to
63.1%) (P=0.183). However, the sensitivity of an
HbA1c threshold of 6.5% was 50.5% (44.7% to
56.3%), which was not significantly different from
that of fasting plasma glucose (P=0.086). At an HbA1c
threshold of 6.5% (table 2), the positive and negative
predictive values were 63.1% (56.6% to 69.2%) and
96.8% (96.2% to 97.3%) and the positive and negative
likelihoodratioswere26.0(20.6to32.9)and0.5(0.5to
0.6). Interestingly, the sensitivity of an HbA1c thresh-
oldof6.3%washigherthanthatofanHbA1cthreshold
of 6.5% (P=0.002).
We did a subgroup analysis of 3639 participants at
highriskofdiabetes(1436menand2203women).The
riskfactorsfordiabetesincludedageover45andbody
mass index over 24.0.
520The median age of this sub-
group was 53.4 (interquartile range 47.0-60.3) years.
Table 3 shows the sensitivity, specificity, positive and
negative predictive value, and positive and negative
likelihood ratio for identifying diabetes at different
HbA1c thresholds. At an HbA1c threshold of 6.3%,
the sensitivity was significantly higher than that of a
fasting plasma glucose threshold of 7.0 mmol/l
(66.9% (61.0% to 72.5%) v 54.4% (48.3% to 60.4%);
P=0.003) with high specificity (94.8%, 94.0% to
95.6%). When we used a threshold of 6.5%, the sensi-
tivitywassignificantlylowerthanthatseenwitha6.3%
threshold (53.7% (47.6% to 59.7%) v 66.9% (61.0% to
72.5%); P=0.002).
Ofthe367participantswithHbA1cof6.3%orabove
(table 4), 74 had normal glucose tolerance, 104 had
impaired glucose regulation, and 189 were designated
as having diabetes when we applied the 1999 WHO
criteria. In contrast, at the HbA1c threshold of 6.5%,
33 had normal glucose tolerance, 56 had impaired
glucose regulation, and 152 were designated as having
diabetes.
Table 5 shows the number and clinical characteris-
ticsofpatientsidentifiedashavingdiabetesonthebasis
of oral glucose tolerance test results with the 1999
WHO criteria and an HbA1c threshold of 6.3%. One
hundred and eighty-nine of the patients identified by
HbA1c overlapped with those diagnosed by using the
WHO criteria. The anthropometric and biochemical
measurements were comparable between the two
groups.
DISCUSSION
Inthiscommunitybasedstudyin4886Chineseadults,
we found that an HbA1c threshold of 6.3% had high
specificity for detecting undiagnosed diabetes and
equal sensitivity to that of a fasting plasma glucose
threshold of 7.0 mmol/l. This threshold was more effi-
cient in the people at high risk of diabetes.
Epidemiology of diabetes
Although the prevalence of diabetes mellitus has dra-
matically increased in recent years in China, the dis-
ease remains underdiagnosed. In the United States,
for every two patients diagnosed as having diabetes
in a hospital, at least one other patient in the hospital
may have unrecognised diabetes and be at higher risk
of poor health outcomes and high healthcare costs.
21
The epidemiological survey for diabetes in Shanghai,
China,foundthattheannualincidenceofdiabeteswas
100 - specificity (%)
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Fig 2 | Receiver operating characteristics curve of HbA1c for
detecting diabetes at each possible HbA1c threshold. Area
under curve=0.856 (95% CI 0.828 to 0.883)
Table 2 |Sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio for detecting
diabetes with fasting plasma glucose (FPG) in 1999 WHO criteria and HbA1c thresholds (n=4886). Values in parentheses are 95% confidence intervals
Sensitivity
(%)
Specificity
(%)
Positive predictive
value (%)
Negative predictive
value (%)
Positive likelihood
ratio
Negative likelihood
ratio
HbA1c threshold (%):
5.9 (1 SD above normal mean) 77.7 (72.6 to 82.3) 78.2 (77.0 to 79.4) 19.0 (16.8 to 21.3) 98.2 (97.7 to 98.6) 3.6 (3.3 to 3.9) 0.3 (0.2 to 0.4)
6.3 (2 SD above normal mean) 62.8 (57.1 to 68.3) 96.1 (95.5 to 96.7) 51.5 (46.3 to 56.7) 97.5 (97.0 to 98.0) 16.2 (13.7 to 19.1) 0.4 (0.3 to 0.5)
6.7 (3 SD above normal mean) 37.9 (32.4 to 43.6) 99.1 (98.7 to 99.3) 72.6 (64.9 to 79.4) 96.1 (95.5 to 96.6) 40.4 (29.0 to 56.2) 0.6 (0.6 to 0.7)
7.1 (4 SD above normal mean) 26.3 (21.4 to 31.6) 99.8 (99.6 to 99.9) 87.8 (79.2 to 93.7) 95.4 (94.8 to 96.0) 109.7 (59.0 to 203.8) 0.7 (0.7 to 0.8)
6.5* 50.5 (44.7 to 56.3) 98.1 (97.6 to 98.4) 63.1 (56.6 to 69.2) 96.8 (96.2 to 97.3) 26.0 (20.6 to 32.9) 0.5 (0.5 to 0.6)
FPG ≥7.0 mmol/l 57.5 (51.7 to 63.1) 100.0 (99.9 to 100.0) 100.0 (97.9 to 100.0) 97.3 (96.8 to 97.7) – 0.4 (0.4 to 0.5)
*Threshold recommended by American Diabetes Association/European Association for the Study of Diabetes/International Diabetes Federation.
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of people with diabetes were undiagnosed before the
survey.
2 More efficient identification of people with
diabetes is thus essential to allow provision of timely
treatment and improve outcomes.
Advantages of HbA1c in diagnosing diabetes
Historically, a lack of standardised HbA1c measure-
ments has meant that the American Diabetes Associa-
tion has not recommended the use of HbA1c as a
diagnostic tool. However, recent improvements in
standardised HbA1c measurements worldwide, espe-
cially a new more specific reference measure devel-
oped in 2003,
22 have prompted re-evaluation of
HbA1c as a screening or diagnostic tool for diabetes.
1
Selvin et al found that the within-personcoefficients of
variationintwohourpost-loadplasmaglucose,fasting
plasma glucose, and HbA1c were in descending fre-
quency(16.7%>5.7%>3.6%).
23Thesefindingsshowed
that HbA1c was more reproducible and repeatable
than fasting plasma glucose as a diagnostic tool for
diabetes.
24
A few practical considerations support the conveni-
enceofHbA1cindiagnosingdiabetes.Firstly,bothfast-
ing plasma glucose and oral glucose tolerance tests
require the patient to fast for at least eight hours,
which decreases the opportunities for diagnosing dia-
betes.However,HbA1ctestingcanbedoneatanytime
without fasting or other preparation of the patient,
which makes diagnosis on the same day possible. Sec-
ondly, both fasting plasma glucose and oral glucose
tolerance tests may be affected by short term lifestyle
changes, such as diet and amount of physical exercise
beforeexamination.Incontrast,the HbA1cvaluedoes
not have such limitations as it reflects mean glycaemia
over the preceding two to three months, which accu-
rately reflects longer term glycaemia.
Recent studies have indicated that HbA1c is similar
orsuperiortofastingplasmaglucoseinscreeningforor
diagnosisofdiabetescomparedwiththegoldstandard,
theoralglucosetolerancetest.
1315Inourstudy,thearea
under the receiver operating characteristics curve was
0.856 for HbA1c for detecting undiagnosed diabetes,
which corresponds to the findings of a study done in
the Japanese population.
12 Another study found that
HbA1c measurement improved the detection of dia-
betes in people at high risk compared with a fasting
plasma glucose threshold of 7.0 mmol/l.
25
Ethnic differences in distribution of hyperglycaemic
categories
Ethnicdifferencesexistinthedistributionofhypergly-
caemiccategories.TheDiabetesEpidemiology:Colla-
borative Analysis of Diagnostic Criteria in Europe
study showed that the proportions of patients with iso-
lated high fasting plasma glucose concentrations, iso-
lated high two hour post-load plasma glucose
concentrations, and high fasting plasma glucose con-
centrations with high two hour post-load plasma glu-
cose concentrations were 40%, 31%, and 29%.
26 Using
only fasting plasma glucose concentrations, about two
thirds of patients with diabetes could be detected.
27
However, the Diabetes Epidemiology: Collaborative
AnalysisofDiagnosticCriteriainAsiastudyfoundcor-
respondingproportionsof19%,44%,and37%.There-
fore, only 56% of patients with diabetes could be
detected with the fasting plasma glucose criterion
alone, which left more Asian patients undiagnosed
than was the case in the European population.
28 The
1994ChinaNationalDiabetesMellitusSurvey ofChi-
nese adults showed that impaired glucose tolerance
was the most common form of impaired glucose regu-
lation and that high fasting plasma glucose concentra-
tions with high two hour post-load plasma glucose
concentrations was the most common subcategory of
diabetes.
29 Our study confirmed the findings of the
China National Diabetes Mellitus Survey, which sug-
gested that a large number of people with diabetes
Table 3 |Sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio for detecting
diabetes with fasting plasma glucose (FPG) in 1999 WHO criteria and HbA1c thresholds in patients at high risk of developing diabetes (n=3639). Values in
parentheses are 95% confidence intervals
Sensitivity
(%)
Specificity
(%)
Positivepredictivevalue
(%)
Negative predictive
value (%)
Positive likelihood
ratio
Negative likelihood
ratio
HbA1c threshold (%):
6.0 79.0 (73.7 to 83.7) 80.3 (78.9 to 81.6) 24.5 (21.7 to 27.5) 97.9 (97.3 to 98.4) 4.0 (3.7 to 4.4) 0.3 (0.2 to 0.3)
6.1 73.9 (68.3 to 79.0) 87.2 (86.0 to 88.3) 31.8 (28.1 to 35.5) 97.6 (97.0 to 98.2) 5.8 (5.1 to 6.5) 0.3 (0.3 to 0.4)
6.2 69.1 (63.3 to 74.6) 91.9 (90.9 to 92.8) 40.7 (36.2 to 45.3) 97.4 (96.7 to 97.9) 8.5 (7.4 to 9.8) 0.3 (0.3 to 0.4)
6.3 66.9 (61.0 to 72.5) 94.8 (94.0 to 95.6) 51.1 (45.8 to 56.4) 97.3 (96.6 to 97.8) 13.0 (11.0 to 15.3) 0.4 (0.3 to 0.4)
6.4 58.8 (52.7 to 64.7) 96.5 (95.8 to 97.1) 57.6 (51.5 to 63.4) 96.7 (96.0 to 97.3) 16.8 (13.7 to 20.6) 0.4 (0.4 to 0.5)
6.5* 53.7 (47.6 to 59.7) 97.4 (96.8 to 97.9) 62.7 (56.1 to 68.9) 96.3 (95.6 to 96.9) 20.8 (16.4 to 26.3) 0.5 (0.4 to 0.5)
FPG ≥7.0 mmol/l 54.4 (48.3 to 60.4) 100.0 (99.9 to 100.0) 100.0 (97.5 to 100.0) 96.5 (95.8 to 97.0) – 0.5 (0.4 to 0.5)
*Threshold recommended by American Diabetes Association/European Association for the Study of Diabetes/International Diabetes Federation.
Table 4 |Distribution of participants with normal glucose tolerance, impaired glucose
regulation, and diabetes stratified by HbA1c thresholds of 6.3% and 6.5%. Values are
numbers (percentages)
HbA
1c (%)
75 g oral glucose tolerance test
Normal glucose tolerance
(n=3748)
Impaired glucose regulation
(n=837)
Diabetes
(n=301)
≥6.3* 74 (2.0) 104 (12.4) 189 (62.8)
≥6.5† 33 (0.9) 56 (6.7) 152 (50.5)
*Threshold found in this study.
†Threshold recommended by American Diabetes Association/European Association for the Study of Diabetes/
International Diabetes Federation.
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plasma glucose test was used. Accordingly, in the Chi-
nese population, use of HbA1c would be more suitable
fordiagnosingdiabetesaccordingtothedistributionof
types of hyperglycaemia.
HbA1c threshold compared with other studies
Racial disparities in HbA1c values exist,
3031 and the
optimal thresholds for detecting diabetes have been
found to vary by ethnic group.
1215 The 1999-2004
National Health and Nutrition Examination Survey
found that an HbA1c value of 6.5% or greater was an
optimal threshold for identifying diabetes in the US
population.
10 Data from the National Health and
Nutrition Examination Survey III (1988-94) found
indications of differences between ethnic groups in
the sensitivity and specificity of HbA1c (at 6.1%) for
detecting undiagnosed diabetes. Sensitivity ranged
from 58.6% in the non-Hispanic white population to
83.6% in the Mexican-American population; specifi-
city ranged from 93.0% in the non-Hispanic black
population to 98.3% in the non-Hispanic white
population.
11 In a multiethnic population in Canada,
the optimal threshold for HbA1c of 5.9% was asso-
ciated with a sensitivity of 75.0% (95% confidence
interval 64.0% to 86.0%) and a specificity of 79.1%
(76.4%to81.8%).
32AstudyoftheHongKongChinese
population with known risk factors for glucose intoler-
ance showed that an HbA1c threshold of 6.1% gave an
optimal sensitivity of 77.5% and specificity of 78.8%
when two hour post-load plasma glucose of at least
11.1mmol/lwasusedasthereference.
33Similarresults
were found in the Japanese population, where the
HbA1c threshold of 6.1% was found to be suitable for
detecting undiagnosed diabetes and predicting vascu-
lar complications.
12
In our community based study, we found that an
HbA1c threshold of 5.9% provided the optimal sensi-
tivity and specificity for screening for potential dia-
betes in the general Chinese population. Recently, an
international expert committee reported that people
with an HbA1c value of at least 6% but less than 6.5%
are likely to be at highest risk for progression to
diabetes.
16 In our study, the proficiency of an HbA1c
thresholdof6.3%fordetectingdiabeteswasequivalent
to that of a fasting plasma glucose threshold of
7.0 mmol/l. However, in people at high risk of dia-
betes, the proficiency of an HbA1c threshold of 6.3%
indetectingdiabeteswassuperiortothatofbothafast-
ing plasma glucose threshold of 7.0 mmol/l and an
HbA1c threshold of 6.5% (66.9% v 54.4% v 53.7%).
On the basis of our results, an HbA1c threshold of
6.3% may be acceptable as a diagnostic criterion for
diabetes in the Chinese population, when fasting
plasma glucose and oral glucose tolerance tests are
not available.
Confounders and limitations of study
Some confounders and effect modifiers influence the
clinicaluseofHbA1cforscreeningforanddiagnosisof
diabetes.Firstly,theHbA1cvaluereflectsmeanglycae-
miaover the precedingtwotothreemonths,so people
with a history of diabetes of less than three months
might not be identified by HbA1c testing. However,
this is extremely unlikely given that on average a
seven year gap exists between the actual onset of dia-
betes and its diagnosis.
34 Secondly, conditions that
shorten survival of erythrocytes, such as haemolytic
anaemia, will decrease the concentration of HbA1c.
Conversely,conditionsthatprolongtheageoferythro-
cytes, such as splenectomy and aplastic anaemia, will
increase the concentration of HbA1c independent of
glycaemia. Haemoglobinopathies such as haemoglo-
bin S (sickle cell) interfere with some assays. Thus,
the use of HbA1c may be inappropriate for such disor-
ders.
Limitations of this studyinclude an inadequate sam-
ple size. Additionally, as the high prevalence of
impaired glucose tolerance has prognostic value
regarding possible progression to diabetes and cardio-
vascular disease, the use of HbA1c alone to diagnose
diabetes could give a false sense of security. Thus, in
patients with known risk factors for glucose intoler-
ance, a 75 g oral glucose tolerance test, yearly HbA1c
Table 5 |Clinical characteristics of participants identified as having diabetes by oral glucose tolerance test and HbA1c
threshold of 6.3%. Values are medians (interquartile ranges) unless stated otherwise
Characteristics
Diabetes identified by oral glucose tolerance test
(n=301)
Diabetes identified by HbA
1c
(n=367)
Mean (SD) age (years) 54.2 (11.9) 56.4 (10.4)
Mean (SD) body mass index (kg/m
2) 25.5 (3.7) 25.8 (3.5)
Mean (SD) waist circumference (cm) 86.4 (10.6) 86.9 (9.8)
Systolic blood pressure (mm Hg) 130.0 (120.0-140.0) 130.0 (120.0-140.0)
Diastolic blood pressure (mm Hg) 80.0 (74.0-90.0) 80.0 (74.0-90.0)
Total cholesterol (mmol/l) 5.0 (4.4-5.7) 5.2 (4.4-5.8)
Triglycerides (mmol/l) 1.8 (1.2-2.9) 1.9 (1.3-2.9)
High density lipoprotein cholesterol (mmol/l) Mean 1.2 (SD 0.3) 1.2 (1.0-1.4)
Low density lipoprotein cholesterol (mmol/l) 3.1 (2.7-3.7) Mean 3.3 (SD 1.0)
Fasting plasma glucose (mmol/l) 7.2 (6.2-8.1) 6.4 (5.7-7.4)
2 hour post-load plasma glucose (mmol/l) 12.7 (11.2-15.2) 10.3 (7.2-13.9)
HbA1c (%) 6.5 (5.9-7.1) 6.6 (6.4-7.0)
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diagnosis and opportunity for therapeutic inter-
vention. Although either plasma glucose concentra-
tions after fasting or two hour post-load plasma
glucose after a 75 g oral glucose tolerance test could
beusedalonefordiagnosingdiabetesinepidemiologi-
cal studies, according to 1999 WHO criteria,
4 addi-
tional testing is desirable to prove the reliability of the
HbA1c threshold in clinical studies. This study should
be validated by similar epidemiological and clinical
studies.
Financial implications
The cost in China of the HbA1c test was similar to that
of the oral glucose tolerance test. However, the first of
these is more acceptable to patients than the second,
because it causes less discomfort. Undiagnosed dia-
betes and its complications cause increased healthcare
costs in America.
35 On the basis of our study, HbA1c
testing might help to reduce these costs by improving
diagnosis of diabetes and enabling more timely thera-
peutic intervention in such patients.
Conclusions
In conclusion, this study found that an HbA1c thresh-
old of 6.3% was highly specific for detecting undiag-
nosed diabetes in Chinese adults and had sensitivity
similar to that of using a fasting plasma glucose thresh-
old of 7.0 mmol/l. These findings suggest that HbA1c,
with the optimal threshold of 6.3%, may be acceptable
as a diagnostic criterion for diabetes in the Chinese
population when fasting plasma glucose and oral glu-
cose tolerance tests are not available.
Contributors: YB, XK, and WJ conceived and designed the study. XM and
XHrecruitedsamples.XMdidthestatisticalanalyses.JTmeasuredHbA1c.
YB and XM wrote the first draft of the paper. YB, XM, CH, and WJ revised
the paper and contributed to discussion. HL, MZ, and HW provided
technicalsupport.YBandXMcontributedequallytothisworkandarethe
guarantors.
Funding: This work was funded by Shanghai United Developing
Technology Project of Municipal Hospitals (SHDC12006101), Chinese
National 973 Project (2007CB914702), Shanghai Key Laboratory of
Diabetes Mellitus (08DZ2230200), Major Program of Shanghai
Municipality for Basic Research (08dj1400601), and National Key
Technology R&D Program of China (2009BAI80B01).
Competing interests: None declared.
Ethical approval: The local ethics committee approved the study, and all
participants gave written informed consent.
Data sharing: No additional data available.
1 Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D,
Davidson MB. A new look at screening and diagnosing diabetes
mellitus. J Clin Endocrinol Metab 2008;93:2447-53.
2 J i aW P ,P a n gC ,C h e nL ,B a oY Q ,L uJ X ,L uH J ,e ta l .E p i d e m i o l o g i c a l
characteristics of diabetes mellitus and impaired glucose regulation
in a Chinese adult population: the Shanghai Diabetes Studies, a
cross-sectional 3-year follow-up study in Shanghai urban
communities. Diabetologia 2007;50:286-92.
3 World Health Organization. The world health report: primary health
care—now more than ever. WHO, 2008.
4 WorldHealthOrganization.Definition,diagnosisandclassificationof
diabetes mellitus and its complications: report of a WHO
consultation. Part 1: diagnosis and classification of diabetes
mellitus. WHO, 1999.
5 Expert Committee on the Diagnosis and Classification of Diabetes
Mellitus. Report of the expert committee on the diagnosis and
classification of diabetes mellitus. Diabetes Care
2003;26(suppl 1):S5-20.
6 L i t t l eR R ,R o h l f i n gC L ,W i e d m e y e rH M ,M y e r sG L ,S a c k sD B ,
Goldstein DE, et al. The national glycohemoglobin standardization
program: a five-year progress report. Clin Chem 2001;47:1985-92.
7 Little RR. Glycated hemoglobin standardization—national
glycohemoglobin standardization program (NGSP) perspective. Clin
Chem Lab Med 2003;41:1191-8.
8 GoldsteinDE,LittleRR,LorenzRA,MaloneJI, NathanD,PetersonCM,
etal.Testsofglycemiaindiabetes.DiabetesCare2004;27:1761-73.
9 StrattonIM,AdlerAI,NeilHA,MatthewsDR,ManleySE,CullCA,etal.
Association of glycaemia with macrovascular and microvascular
complications of type 2 diabetes (UKPDS 35): prospective
observational study. BMJ 2000;321:405-12.
10 BuellC,KermahD,DavidsonMB.UtilityofA1Cfordiabetesscreening
in the 1999-2004 NHANES population. Diabetes Care
2007;30:2233-5.
11 Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Madsen R,
Harris MI, et al. Use of GHb (HbA1c)i ns c r e e n i n gf o ru n d i a g n o s e d
diabetes in the US population. Diabetes Care 2000;23:187-91.
12 Nakagami T, Tominaga M, Nishimura R, Yoshiike N, Daimon M,
Oizumi T, et al. Is the measurement of glycated hemoglobin A1c
alone an efficient screening test for undiagnosed diabetes? Japan
National Diabetes Survey. Diabetes Res Clin Pract 2007;76:251-6.
13 Wiener K, Roberts NB. The relative merits of haemoglobin A1c and
fasting plasma glucose as first-line diagnostic tests for diabetes
mellitus in non-pregnant subjects. Diabet Med 1998;15:558-63.
14 Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the
diagnosis of type 2 diabetes mellitus. Ann Intern Med
2002;137:263-72.
15 Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for
detection of type 2 diabetes: a systematic review. Diabet Med
2007;24:333-43.
16 International Expert Committee. International Expert Committee
report on the role of the A1c assay in the diagnosis of diabetes.
Diabetes Care 2009;32:1327-34.
17 Olabi B, Bhopal R. Diagnosis of diabetes using the oral glucose
tolerance test. BMJ 2009;339:b4354.
18 WHO Expert Committee on Diabetes Mellitus. Second report.
Technical report series no 646. WHO, 1980.
19 HanleyJA,McNeilBJ.Amethodofcomparingtheareasunderreceiver
operating characteristic curves derived from the same cases.
Radiology 1983;148:839-43.
20 Zhou B, Wu Y, Yang J, Li Y, Zhang H, Zhao L. Overweight is an
independent risk factor for cardiovascular disease in Chinese
populations. Obes Rev 2002;3:147-56.
21 ACE/ADA Task Force on Inpatient Diabetes. American College of
Endocrinology and American Diabetes Association consensus
statement on inpatient diabetes and glycaemic control. Diabetes
Care 2006;29:1955-62.
22 Miedema K. Towards worldwide standardisation of HbA1c
determination. Diabetologia 2004;47:1143-8.
23 Selvin E, Crainiceanu CM, Brancati FL,Coresh J. Short-term variability
in measures of glycemia and implications for the classification of
diabetes. Arch Intern Med 2007;167:1545-51.
24 Lacher DA, Hughes JP, Carroll MD. Estimate of biological variation of
laboratory analytes based on the third national health and nutrition
examination survey. Clin Chem 2005;51:450-2.
25 Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD. HbA1c
measurement improves the detection of type 2 diabetes in high-risk
individuals with nondiagnostic levels of fasting plasma glucose: the
Early Diabetes Intervention Program (EDIP). Diabetes Care
2001;24:465-71.
26 DECODE Study Group on behalf of the European Diabetes
Epidemiology Study Group. Will new diagnostic criteria for diabetes
mellitus change phenotype of patients with diabetes? Reanalysis of
European epidemiological data. BMJ 1998;317:371-5.
WHAT IS ALREADY KNOWN ON THIS TOPIC
HbA1c might be a useful tool for screening for and diagnosis of diabetes
InJune2009,aninternationalexpertcommitteepublishedareportrecommendingthe useof
an HbA1c value of 6.5% or more as a diagnostic criterion for diabetes
As racial disparities in HbA1c levels exist, the optimal threshold for diagnosing diabetes
varies by ethnic group
WHAT THIS STUDY ADDS
In the Chinese population, an HbA1c threshold of 6.3% may be acceptable as a diagnostic
criterion for diabetes
In people at high risk of diabetes, an HbA1c threshold of 6.3% was more efficient than a
fasting plasma glucose threshold of 7.0 mmol/l
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 7 of 827 DECODE Study Group. Glucose tolerance and cardiovascular
mortality: comparison of fasting and 2-hour diagnostic criteria. Arch
Intern Med 2001;161:397-405.
28 Qiao Q, Nakagami T, Tuomilehto J, Borch-Johnsen K, Balkau B,
Iwamoto Y, et al. Comparison of the fasting and the 2-h glucose
criteria for diabetes in different Asian cohorts. Diabetologia
2000;43:1470-5.
29 Yang ZJ, Yang WY, Li GW; National Diabetes Prevention and Control
Cooperative Group. The distributive characteristics of impaired
glucose metabolism subcategories in Chinese adult population.
Zhonghua Yi Xue Za Zhi 2003;83:2128-31.
3 0 H e r m a nW H ,M aY ,U w a i f oG ,H a f f n e rS ,K a h nS E ,H o r t o nE S ,e ta l .
Differences in A1C by race and ethnicity among patients with
impaired glucose tolerance in the Diabetes Prevention Program.
Diabetes Care 2007;30:2753-7.
3 1 V i b e r t iG ,L a c h i nJ ,H o l m a nR ,Z i n m a nB ,H a f f n e rS ,K r a v i t zB ,e ta l .A
Diabetes Outcome Progression Trial (ADOPT): baseline
characteristics of type 2 diabetic patients in North America and
Europe. Diabet Med 2006;23:1289-94.
3 2 A n a n dS S ,R a z a kF ,V u k s a nV ,G e r s t e i nH C ,M a l m b e r gK ,Y iQ ,e ta l .
Diagnostic strategies to detect glucose intolerance in a multiethnic
population. Diabetes Care 2003;26:290-6.
33 Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, et al. Combined
use of a fasting plasma glucose concentration and HbA1c or
fructosamine predicts the likelihood of having diabetes in high-risk
subjects. Diabetes Care 1998;21:1221-5.
34 Harris MI. Undiagnosed NIDDM: clinical and public health issues.
Diabetes Care 1993;16:642-52.
35 Z h a n gY ,D a l lT M ,M a n nS E ,C h e nY ,M a r t i nJ ,M o o r eV ,e ta l .T h e
economic costs of undiagnosed diabetes. Popul Health Manag
2009;12:95-101.
Accepted: 6 April 2010
RESEARCH
page 8 of 8 BMJ | ONLINE FIRST | bmj.com